Covidien is planning management changes that company leadership claims will "streamline its organization to accelerate growth and innovation."
These changes will take effect July 1.
Bryan C. Hanson will become group president, with responsibility for the Surgical Devices and Energy-based Devices businesses. Bryan joined Covidien in 1992 and has held several positions of increasing responsibility, including his current position, president, Energy-based Devices.
Peter L. Wehrly will become group president, with responsibility for the Respiratory & Monitoring Solutions and Vascular Therapies businesses, as well as regional responsibility for Japan, Australia-New Zealand and Canada. Pete joined Covidien in 2009 as president, Respiratory & Monitoring Solutions, and has more than 20 years of experience in the medical devices industry.
Michael Sgrignari will become senior vice president, Quality and Operations, with global responsibility for Quality Assurance, Regulatory Affairs, Logistics, Environmental Health & Safety and Operational Excellence. Mike joined Covidien in 1991 and has held a number of increasingly responsible positions in manufacturing and operations during his tenure.
Bryan, Pete and Mike will all report to Joe E. Almeida, currently President, Medical Devices and CEO-elect. The position of president, Medical Devices, will be eliminated, but Medical Devices will remain an external reporting segment.
James M. Muse, senior vice president, Global Supply Chain, will retire after 32 years of outstanding service. Scott Flora, president, Surgical Devices, who successfully led the business for the past five years, will leave Covidien to pursue other career opportunities, according to a press release.
"These appointments will enhance our ability to deliver strong, sustained and profitable growth as we execute against our strategic initiatives," said Almeida. "I'd like to thank Jim and Scott for their years of service to Covidien and wish them the best in their future endeavors."